Avantor Sees $3.5 Million Bet Amid 54% Stock Drop

Avantor's stock has dropped 54% over the past year, but a new position by Circumference Group acquiring 305,000 shares worth $3.5 million targets the company. Avantor offers a comprehensive portfolio of laboratory materials and services for biopharma, healthcare, education, and advanced technologies sectors, generating revenue through high-purity chemicals, reagents, and lab supplies. The company's scale, operational expertise, and focus on high-growth end markets underpin its competitive positioning in the healthcare and scientific supply chain.